Introducing the Accrual to Clinical Trials (ACT) Network
The Accrual to Clinical Trials (ACT) Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across the NCATS Clinical and Translational Science Award (CTSA) consortium. ACT helps researchers design and complete clinical studies, and is secure, HIPPA-compliant and IRB-approved. The ACT Network currently contains de-identified data of approximately 100 million patients from 32 CTSAs across the country, expanding to 48 CTSAs in 2019 (approximately 80% of the CTSA consortium).
Daniel Harris, Ph.D.
Director of Clinical Research Analytics
Institute for Pharmaceutical Outcomes & Polity (IPOP)
Center for Clinical and Translational Sciences (CCTS)
University of Kentucky
Registration is required. Email email@example.com by Tuesday, May 14, 2019. If you required special physical arrangements to attend, please call 323-8545.
A pizza lunch will be served beginning at 11:50 am.